Connection

Bikash Medhi to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications Bikash Medhi has written about Drug Evaluation, Preclinical.
Bikash Medhi
Connection Strength
0.751
Drug Evaluation, Preclinical
  1. Virtual screening and molecular dynamics study of approved drugs as inhibitors of spike protein S1 domain and ACE2 interaction in SARS-CoV-2. J Mol Graph Model. 2020 12; 101:107716.
    View in: PubMed
    Score: 0.362
  2. Developing and sustaining India's capacity for preclinical drug discovery. Indian J Pharmacol. 2018 Sep-Oct; 50(5):225-226.
    View in: PubMed
    Score: 0.316
  3. Experience of an academic institute in importing a novel preclinical drug into India. Indian J Pharmacol. 2017 Jul-Aug; 49(4):322-324.
    View in: PubMed
    Score: 0.073
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.